AAAAAA
Results:
1-7
|
Results: 7
Authors:
Boerner, AR
Weckesser, M
Herzog, H
Schmitz, T
Audretsch, W
Nitz, U
Bender, HG
Mueller-Gaertner, HW
Citation: Ar. Boerner et al., Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer, EUR J NUCL, 26(3), 1999, pp. 226-230
Authors:
Hepp, H
Untch, M
Bender, HG
Nitz, U
Citation: H. Hepp et al., Metastatic breast cancer - Part 2, GYNAKOLOGE, 32(9), 1999, pp. 665-665
Authors:
Mohrmann, S
Nitz, U
Citation: S. Mohrmann et U. Nitz, Locoregional intraarterial chemotherapy in primary incurable breast cancerrecurrences, GYNAKOLOGE, 32(9), 1999, pp. 689-694
Authors:
Hepp, H
Untch, M
Bender, HG
Nitz, U
Citation: H. Hepp et al., Metastatic breast cancer - Part 1, GYNAKOLOGE, 32(8), 1999, pp. 593-593
Authors:
Bender, HG
Nitz, U
Citation: Hg. Bender et U. Nitz, Difficulties in distinguishing between locoregional and peripheral breast cancer metastases, GYNAKOLOGE, 32(8), 1999, pp. 594-596
Authors:
Nitz, U
Mohrmann, S
Bender, HG
Citation: U. Nitz et al., High dose chemotherapy with peripheral blood progenitor support in metastatic breast cancer, GYNAKOLOGE, 32(8), 1999, pp. 632-637
Authors:
Hoffken, K
Diehl, V
Kanz, L
Possinger, K
Zander, A
Kreienberg, R
Bender, HG
Elling, D
Jackisch, C
Luck, HJ
Mobus, V
Nitz, U
Thomssen, C
Untch, M
Gaisser, A
Citation: K. Hoffken et al., High dose treatment of mammary carcinoma. "Wait and see" is the reaction to the results of the randomized studies presented at the ASCO 1999 in Atlanta, GYNAKOLOGE, 32(8), 1999, pp. 655-655
Risultati:
1-7
|